glp 1 and breast cancer GLP-1 receptor agonists (GLP-1 RAs) are associated with reduced incidence of among women with overweight or obesity, according to two observational studies. One found that GLP-1 RA users had a GLP-1 Lower Breast Cancer Risk

I started taking AG1 way back in 2012

Glob Health Promot 27:1523

Trade-offs in evolutionary immunology: just what is the cost of immunity

Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations

Standard treatmentsrest, ice, anti-inflammatories, and physical therapyprovide symptom relief but do little to address the underlying hypovascularity

The peptide BPC-157 has not been evaluated for safety as part of the drug review process of the United States Food and Drug Administration (FDA), nor has it been formally evaluated for safety by any international regulatory counterpart of the FDA